Back
Ultragenyx Pharmaceutical Stock Price Chart
Don't put a penny in AI stocks until you read this
Discover this under-the-radar AI stock now, ahead of the crowd.
Sell
47
RARE
Ultragenyx Pharmaceutical
Last Price:
54.85
Seasonality Move:
12.42%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- The current trend is moderately bearish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.68 | Sell |
| 20-day SMA: | 55.18 | Sell |
| 50-day SMA: | 55.69 | Sell |
| 200-day SMA: | 47.54 | Buy |
| 8-day EMA: | 55.4 | Sell |
| 20-day EMA: | 55.43 | Sell |
| 50-day EMA: | 54.18 | Buy |
| 200-day EMA: | 48.46 | Buy |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 47.17 | Sell |
| Chaikin Money Flow: | 157903 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.97 - 57.61) | Sell |
| Bollinger Bands (100): | (42.49 - 56.25) | Buy |
Ultragenyx Pharmaceutical Technical Analysis
| Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.79 while RARE 8-day simple moving average is 55.68, which is a Sell signal.
- The stock price of RARE is 54.79 while Ultragenyx Pharmaceutical 20-day SMA is 55.18, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day simple moving average is 55.69 while RARE share price is 54.79, making it a Sell technically.
- RARE stock price is 54.79 and Ultragenyx Pharmaceutical 200-day simple moving average is 47.54, creating a Buy signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a Sell
The current Ultragenyx Pharmaceutical [RARE] share price is $54.79. The Score for RARE is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
5.05B
Price in USD:
54.79
Share Volume:
349.38K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
31.52
Sell
47
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?
The Ultragenyx Pharmaceutical stock price is 54.79 USD today. -
Will RARE stock go up or go down?
Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators -
Is Ultragenyx Pharmaceutical overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
- Ultragenyx Pharmaceutical share price is 54.79 while RARE 8-day exponential moving average is 55.40, which is a Sell signal.
- The stock price of RARE is 54.79 while Ultragenyx Pharmaceutical 20-day EMA is 55.43, which makes it a Sell.
- Ultragenyx Pharmaceutical 50-day exponential moving average is 54.18 while RARE share price is 54.79, making it a Buy technically.
- RARE stock price is 54.79 and Ultragenyx Pharmaceutical 200-day simple moving average is 48.46, creating a Buy signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.05 per share, and an increase next year of $1.10 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
- RARE Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Ultragenyx Pharmaceutical is a Buy
- Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 47.17, which suggest Ultragenyx Pharmaceutical is oversold
- The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (53.97 - 57.61), which suggest Ultragenyx Pharmaceutical is a Buy
- The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (42.49 - 56.25), which suggest Ultragenyx Pharmaceutical is a Buy
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.